MacroGenics to Participate in Upcoming Investor Conference
February 02, 2024 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Feb. 02, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Global Biosimilars and Biologics Market Surges: $46.11 Billion Market Forecast for 2028 - Industry Trends and Strategic Analysis
February 02, 2024 10:43 ET
|
Research and Markets
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimilars and Biologics Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19, Ansoff Analysis"...
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry: 1-Day Online Training Course (June 21st, 2024)
January 31, 2024 05:18 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Training Course" conference has been added to ...
CDMO Market Surges Towards USD 322.7 Billion by 2033 | Analyzing Growth in Pharmaceutical Manufacturing
January 30, 2024 02:34 ET
|
Market.Us
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global CDMO market size is forecasted to exceed USD 322.7 Billion by 2033, with a promising CAGR of 7.2% from 2024 to 2033. A...
Synthetic Biology Market Set to Hit USD 96.4 Billion by 2033, Riding on a Strong 19.3% CAGR | Market.us
January 29, 2024 04:15 ET
|
Market.Us
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Synthetic Biology Market size is projected to exceed USD 96.4 Billion by 2033, with a promising CAGR of 19.3% from 2024 to...
Human Microbiome Market Set to Surge from USD 0.77 Billion to USD 1.65 Billion by 2028, Finds New Research
January 26, 2024 04:53 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Human Microbiome Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ResearchAndMarkets.com's...
Biological Safety Testing Market Forecast 2023-2033: A $16.5 Billion Industry Opportunity, Dominated by Cytovance Biologics, Toxikon, Avance Biosciences, Merck, and WuXi AppTec
January 25, 2024 10:10 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Biological Safety Testing Market Analysis & Forecast to 2023-2033: Market By Product; By Application; By Test; By End-user; and By Region"...
Global mRNA Therapeutics Market Set to Reach $21 Billion by 2028 Despite Decline, Fueled by Next-Gen Drugs
January 25, 2024 09:54 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics reached $60...
Biologics Testing Global Market Report 2024: Rapid Growth Projected Due to Asian-Pacific Expansion and Technological Innovations - Long-term Forecasts to 2028 and 2033
January 25, 2024 07:42 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Biologics Testing Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Biologics Testing Industry Analysis...
Biopharmaceuticals Market Forecast to Surge at 7.98% CAGR Through 2028 Driven by Chronic Disease Prevalence and Advancements in Personalized Medicines
January 25, 2024 05:11 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. ...